Validity of minimal clinically important difference values for the multiple sclerosis walking scale-12?

European Neurology

Volumn 71, Issue 3-4, 2014, Pages 196-202

  Motl, Robert W ^a   Learmonth, Yvonne C ^a   Pilutti, Lara A ^a   Dlugonski, Deirdre ^a   Klaren, Rachel ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Clinical meaningfulness; Disability; Multiple sclerosis; Walking

Indexed keywords

6 MIN WALK; ACCELEROMETRY; ADULT; ANALYSIS OF VARIANCE; ARTICLE; GAIT; HEALTH STATUS; HUMAN; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS WALKING SCALE 12; PRIORITY JOURNAL; RATING SCALE; TIMED 25 FT WALK; WALKING; ACCELEROMETER; ANALYTICAL PARAMETERS; CLINICAL ASSESSMENT TOOL; CONSTRUCT VALIDITY; DISEASE DURATION; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; MAJOR CLINICAL STUDY; MALE; MINIMAL CLINICALLY IMPORTANT DIFFERENCE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCEPTION; PHYSICAL ACTIVITY; PROSPECTIVE STUDY;

4 AMINOPYRIDINE;

DISABILITY EVALUATION; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; WALKING;

EID: 84892729641     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000356116     Document Type: Article

References (20)

1. Riazi A: Patient-reported outcome measures in multiple sclerosis. Int MS J 2006; 13: 92-99.
2. Food and Drug Administration: Guidance for industry: patient-reported outcome measures - use in medical product development to support labeling claims. 2009. http:// www.fda.gov/downloads/Drugs/Guidance ComplianceRegulatoryInformation/ Guidances/UCM193282.pdf (accessed May 20, 2013).
3. Cohen JA, Reingold SC, Polman CH, Wolinski JS: Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects. Lancet Neurol 2012; 11: 467-476.
4. Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ: Measuring the impact of MS on walking ability: the 12-item MS Walking Scale (MSWS-12). Neurology 2003; 60: 31-36.
5. Pilutti LA, Dlugonski D, Sandroff BM, Suh Y, Pula JH, Sosnoff JJ, Motl RW: Further validation of Multiple Sclerosis Walking Scale-12 scores based on spatiotemporal gait parameters. Arch Phys Med Rehabil 2013; 94: 575-578.
6. Hobart J: Prolonged-release fampridine for multiple sclerosis: was the effect on walking ability clinically significant. Mult Scler 2010; 16:S172.
7. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al: Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 2008; 9: 105-121.
8. Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A: The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measures. Brain 2001; 124: 962-973.
9. Goldman MD, Marrie RA, Cohen JA: Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Mult Scler 2008; 14: 383-390.
10. Fischer JS, Rudick RA, Cutter GR, Reingold SC: The Multiple Sclerosis Functional Composite measure (MFSC): an integrated approach to MS clinical outcome assessment - National MS Society Clinical Outcomes Assessment Task Force. Mult Scler 1999; 5: 244-250.
11. Sosnoff JJ, Sandroff B, Motl RW: Quantifying gait abnormalities in persons with multiple sclerosis with minimal disability. Gait Posture 2012; 36: 154-156.
12. Motl RW, Pilutti L, Sandroff BM, Dlugonski D, Sosnoff JJ, Pula JH: Accelerometry as a measure of walking behavior in multiple sclerosis. Acta Neurol Scand 2013; 127: 384-390.
13. Motl RW, Zhu W, Park Y, McAuley E, Scott JA, Snook EM: Reliability of scores from physical activity monitors in adults with multiple sclerosis. Adapt Phys Activ Q 2007; 24: 245-253.
14. Hadjimichael O, Kerns RD, Rizzo MA, Cutter G, Vollmer T: Persistent pain and uncomfortable sensations in persons with multiple sclerosis. Pain 2007; 127: 35-41.
15. Cohen J: Statistical Power Analysis for the Behavioral Sciences, ed 2. Hillsdale, Erlbaum, 1988.
16. Atkinson G, Nevill AM: Statistical methods for assessing measurement error (reliability) in variables relevant to sports medicine. Sports Med 1998; 26: 217-238.
17. Kieseier BC, Pozzilli C: Assessing walking disability in multiple sclerosis. Mult Scler 2012; 18: 914-924.
18. Motl RW: Ambulation and multiple sclerosis. Phys Med Rehabil Clin 2013; 24: 325-336.
19. Freeman J, Walters R, Ingram W, Slade A, Hobart J, Zajicek J: Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measures. Mult Scler 2013; 19: 1632-1639.
20. Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.